Literature DB >> 16778426

Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests.

U Buettiker1, M Keller, W J Pichler, L R Braathen, N Yawalkar.   

Abstract

BACKGROUND: Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous eruption which is often provoked by drugs. CASE REPORT: We report 2 cases of AGEP which showed rapidly spreading pustular eruptions accompanied by malaise, fever and neutrophilia after the administration of systemic prednisolone (corticosteroid of group A, hydrocortisone type). The histological examination showing neutrophilic subcorneal spongiform pustules was consistent with the diagnosis of AGEP. In both cases the rash cleared within a week upon treatment with topical steroids (corticosteroid of group D1, betamethasonedipropionate type and corticosteroid of group D2, hydrocortisone-17-butyrate type). Three months after recovery, the sensitization to corticosteroids of group A was confirmed by epicutaneous testing and positive lymphocyte transformation tests.
CONCLUSION: These cases show that systemic corticosteroids can induce AGEP and demonstrate that epicutaneous testing and lymphocyte transformation tests may be helpful in identifying the causative drug. Our data support previous reports indicating an important role for drug-specific T cells in inducing neutrophil inflammation in this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778426     DOI: 10.1159/000092837

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  6 in total

1.  Acute Generalized Exanthematous Pustulosis: A Painful and Pruritic Presentation of Pustulosis Following Pharmacotherapy for Pharyngeal Phlegmon.

Authors:  Chase Silvers; John Casey
Journal:  Cureus       Date:  2022-04-12

Review 2.  Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy.

Authors:  Laurence Feldmeyer; Kristine Heidemeyer; Nikhil Yawalkar
Journal:  Int J Mol Sci       Date:  2016-07-27       Impact factor: 5.923

3.  Rapid Involution of Pustules during Topical Steroid Treatment of Acute Generalized Exanthematous Pustulosis.

Authors:  Christiane Kley; Carla Murer; Julia-Tatjana Maul; Barbara Meier; Florian Anzengruber; Alexander A Navarini
Journal:  Case Rep Dermatol       Date:  2017-04-27

4.  Acute Generalised Exanthematous Pustulosis: An Update.

Authors:  Abhishek De; Sudip Das; Aarti Sarda; Dayamay Pal; Projna Biswas
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

5.  Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit.

Authors:  Fatemeh Mohaghegh; Parvaneh Hatami; Zeinab Aryanian; Farahnaz Fatemi; Zeinab Mohseni Afshar
Journal:  Case Rep Med       Date:  2022-08-10

6.  Acute generalized exanthematous pustulosis induced by etanercept: another dermatologic adverse effect.

Authors:  Mukaddes Kavala; Ilkin Zindancı; Zafer Türkoglu; Burçe Can; Emek Kocatürk; Serkan Senol; Filiz Topaloglu
Journal:  Case Rep Dermatol Med       Date:  2013-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.